Executive Insights
Cost, risk, and governance framing for CEOs, CFOs, and directors — the business case for testing, not the field-level how-to.
The Real Cost of a Failed Healthcare IT Go-Live
A board-level breakdown of what a failed healthcare IT go-live actually costs — delayed revenue, emergency spend, staff burnout, and compliance exposure — and how to avoid it.
What Claim Denials Really Cost Your Revenue Cycle
A revenue-cycle cost breakdown of preventable, format-level claim denials — the rework, staff time, and cash-flow drag caused by EDI errors that testing should have caught.
Buy vs. Build: The True Cost of a Healthcare Test Data Program
A fair, side-by-side look at building an in-house synthetic healthcare test data generator versus buying one — initial cost, hidden maintenance burden, and when building is actually the right call.
Healthcare IT Go-Live Readiness: Patterns We're Seeing in 2026
An industry-perspective look at recurring patterns in healthcare IT go-live readiness in 2026 — observed themes from implementation work, not a formal survey.
What Your Board Needs to Know About Test Data Risk
A board-level briefing on why real or de-identified patient data in test environments is a governance risk, and the questions directors should be asking leadership.
The ROI of Synthetic Test Data: A CFO's Framework for Justifying the Investment
A practical framework CFOs can use to weigh the predictable cost of synthetic test data against the volatile cost of testing healthcare IT systems on thin, unrepresentative data.
How to Evaluate a Test Data Vendor: A Risk Scorecard for Directors
A vendor-neutral scorecard IT directors and security leaders can use to evaluate any synthetic or test-data vendor across PHI exposure, compliance, coverage, and continuity risk.